Latest News

SMAART-MAP is a platform trial testing supportive treatments added to standard treatment. The trial aims to improve short-term recovery in children hospitalised with severe malaria.
The PIPELINE project, a groundbreaking initiative aimed at enhancing preparedness and response to infections affecting pregnant people and infants across Europe, officially kicked off this week.
The trial found that levofloxacin, taken for six months once daily, substantially reduced the risk of developing drug-resistant TB.
As the final instalment of our 25 at 25 series, we look back at some of the successes of trials we have run that have tested using drugs beyond their original licence.
We look back on the remarkable success of the PROUD study as part of our ’25 at 25’ series celebrating the MRC Clinical Trials Unit’s 25th anniversary.